WallStreetZenWallStreetZen

NASDAQ: INMB
Inmune Bio Inc Stock Ownership - Who owns Inmune Bio?

Insider buying vs selling

Have Inmune Bio Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Scott JudaDirector2023-11-107,000$6.95
$48.65kBuy
Timothy J. SchroederDirector2023-07-1210,000$11.01
$110.08kSell

1 of 1

INMB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INMB insiders and whales buy or sell their stock.

INMB Shareholders

What type of owners hold Inmune Bio Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Xencor Inc10.46%1,885,533$21.93MInsider
Raymond Joseph Tesi8.44%1,520,698$17.69MInsider
Mark William Lowdell8.30%1,496,383$17.40MInsider
David J. Moss6.94%1,250,151$14.54MInsider
Linda F. Powers5.05%910,000$10.58MInsider
Vanguard Group Inc3.00%541,329$6.30MInstitution
Blackrock Inc1.43%257,929$3.00MInstitution
Rhenman Partners Asset Management Ab0.99%178,284$2.07MInstitution
Geode Capital Management LLC0.94%170,040$1.98MInstitution
Janney Montgomery Scott LLC0.91%163,559$1.90MInstitution

1 of 3

INMB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INMB12.71%40.17%Net Selling
CAPR11.25%88.75%Net Buying
ZVRA35.01%33.38%Net Buying
MACK23.49%76.51%Net Buying
ATNM15.63%84.37%

Inmune Bio Stock Ownership FAQ

Who owns Inmune Bio?

Inmune Bio (NASDAQ: INMB) is owned by 12.71% institutional shareholders, 40.17% Inmune Bio insiders, and 47.12% retail investors. Xencor Inc is the largest individual Inmune Bio shareholder, owning 1.89M shares representing 10.46% of the company. Xencor Inc's Inmune Bio shares are currently valued at $22.16M.

If you're new to stock investing, here's how to buy Inmune Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.